群体虚拟运动对帕金森病患者的影响:一项随机对照试验
Sarah C Fishel1,2, Megan E Hotchkiss1, Christine A McNamara1
1Department of Physical Therapy, Ithaca College, Ithaca, NY, USA.
Physiotherapy theory and practice
|October 27, 2024
概括
高强度虚拟运动,个人和团体,显著改善了帕金森病 (PwPD) 患者的平衡和运动能力. 这种方法提高了PwPD受益炼计划的可访问性.
科学领域:
- 神经学 神经学
- 运动科学 运动科学
- 康复医学 康复医学 康复医学
背景情况:
- 高强度运动可以改善帕金森病患者的功能和生活质量 (QoL).
- 个性化的虚拟炼计划已经证明了PwPD的有效性.
- 对于普华永道的虚拟集团活动的影响和可行性仍未得到充分研究.
研究的目的:
- 为了比较个人与团体虚拟炼对PwPD功能移动性和QoL的影响.
主要方法:
- 20名PwPD被随机分配到个性化 (n=10) 或团体 (n=10) 虚拟炼计划中.
- 运动每周进行两次,持续8周,对强度 (心率) 进行监测.
- 结果包括平衡,步行速度/耐力,运动功能,生活质量和自我有效性,通过ANOVA和非参数测试进行分析.
主要成果:
- 参与者参加了>75%的会议,其中>70%达到≥65%HR最大强度.
- 在平衡,步行速度和耐力 (大效果大小) 方面,在小组内观察到统计学上显著的改善.
- 对于任何结果,个人和小组格式之间没有发现显著差异.
结论:
- 高强度的虚拟运动,无论是个人还是团体形式,都是安全有效的,可以改善社区生活PwPD的平衡和流动性.
- 虚拟练习计划可以为PwPD扩大获得高质量的干预措施的机会.
- 集团虚拟练习是PwPD的一个可行和有效的模式.
更多相关视频
07:27Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty
Published on: October 6, 2016
10.2K
05:54A Rehabilitation Program of Exoskeleton-assisted Body Weight-Supported Treadmill Training with Non-immersive Virtual Reality for Stroke Patients
Published on: May 16, 2025
107
相关概念视频
01:24Parkinson's Disease: Treatment
227
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
227
01:15Parkinson's Disease: Overview
486
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
486